PROSPECTIVE RANDOMIZED STUDY OF THE ROLE OF N-ACETYL CYSTEINE IN REVERSING DOXORUBICIN-INDUCED CARDIOMYOPATHY

被引：68

作者：

DRESDALE, AR

BARR, LH

BONOW, RO

MATHISEN, DJ

MYERS, CE

SCHWARTZ, DE

DANGELO, T

ROSENBERG, SA

机构：

[1] NCI,DIV CANC TREATMENT,SURG BRANCH,BLDG 10,ROOM 10N116,BETHESDA,MD 20205

[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20205

[3] NHLI,CARDIOL BRANCH,BETHESDA,MD 20205

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 06期

关键词：

D O I：

10.1097/00000421-198212000-00015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：657 / 663

页数：7

共 29 条

[21]

2-U

[22]

MYERS CE, 1976, CANCER TREAT REP, V60, P961

[23] ADRIAMYCIN - ROLE OF LIPID PEROXIDATION IN CARDIAC TOXICITY AND TUMOR RESPONSE [J].

MYERS, CE ;

MCGUIRE, WP ;

LISS, RH ;

IFRIM, I ;

GROTZINGER, K ;

YOUNG, RC .

SCIENCE, 1977, 197 (4299) :165-167

[24]

PAVEL DG, 1977, J NUCL MED, V18, P305

[25] ADRIAMYCIN CARDIOTOXICITY IN MAN [J].

RINEHART, JJ ;

LEWIS, RP ;

BALCERZA.SP .

ANNALS OF INTERNAL MEDICINE, 1974, 81 (04) :475-478

[26]

SONNEVELD P, 1978, CANCER TREAT REP, V62, P1033

[27]

TAN C, 1973, CANCER-AM CANCER SOC, V32, P9, DOI 10.1002/1097-0142(197307)32:1<9::AID-CNCR2820320102>3.0.CO

[28]

2-6

[29] RISK-FACTORS FOR DOXORUBICIN-INDUCED CONGESTIVE HEART-FAILURE [J].

VONHOFF, DD ;

LAYARD, MW ;

BASA, P ;

DAVIS, HL ;

VONHOFF, AL ;

ROZENCWEIG, M ;

MUGGIA, FM .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) :710-717

← 1 2 3 →